CAS: 2088939-99-3
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | LYN-1604 REF: AN-AG01EOPNCAS: 2088939-99-3 | ≥98% | A consultar | Vie 31 May 24 |
 | LYN-1604 REF: TM-T4123CAS: 2088939-99-3 | 98% | 92,00 €~1.068,00 € | Lun 03 Jun 24 |
 | LYN-1604 REF: 3D-NID93999CAS: 2088939-99-3 | Min. 95% | A consultar | Vie 12 Jul 24 |
Ref: AN-AG01EOPN
| 1mg | 103,00 € | |
| 5mg | 237,00 € | |
| 10mg | 528,00 € | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 31 de Mayo de 2024
LYN-1604
CAS:2088939-99-3
LYN-1604 is a novel activator of ULK1, inducing cell death involved in ATF3, RAD21, and …
Fórmula:
C33H43Cl2N3O2
Pureza:
98%
Forma y color:
Solid
Peso molecular:
584.62
Ref: TM-T4123
| 25mg | 592,00 € | |
| 50mg | 775,00 € | |
| 100mg | 1.068,00 € | |
| 1ml*10 (DMSO) | 277,00 € |
Entrega estimada en Estados Unidos, el Lunes 3 de Junio de 2024
LYN-1604
CAS:2088939-99-3
LYN-1604 is a small-molecule drug that is a potential drug target for cancer therapy. It …
Fórmula:
C33H45Cl4N3O2
Pureza:
Min. 95%
Peso molecular:
657.54 g/mol
Ref: 3D-NID93999
| 1mg | A consultar | |
| 2mg | A consultar | |
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 12 de Julio de 2024
